An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some experts said the demand for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.
Platform Response and Material Elimination
Based on TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of weight loss, glowing reviews and detailed guides for mixing or injecting at residence.
Within minutes of joining one group, a seller posted contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.
Product Details and Costs
Inside these communities, messages display black plastic parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to possibly serious health risks”.
